These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

279 related articles for article (PubMed ID: 18234132)

  • 1. Influences of weight loss on long-term diabetes outcomes.
    Aucott LS
    Proc Nutr Soc; 2008 Feb; 67(1):54-9. PubMed ID: 18234132
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Weight loss in obese diabetic and non-diabetic individuals and long-term diabetes outcomes--a systematic review.
    Aucott L; Poobalan A; Smith WC; Avenell A; Jung R; Broom J; Grant AM
    Diabetes Obes Metab; 2004 Mar; 6(2):85-94. PubMed ID: 14746573
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Weight Changes in General Practice.
    Køster-Rasmussen R
    Dan Med J; 2017 Jun; 64(6):. PubMed ID: 28566125
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of weight loss interventions on patient-reported outcomes in overweight and obese adults with type 2 diabetes: a systematic review.
    Martenstyn J; King M; Rutherford C
    J Behav Med; 2020 Dec; 43(6):873-891. PubMed ID: 32060765
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Contraindications to weight reduction].
    Heini A
    Ther Umsch; 2000 Aug; 57(8):537-41. PubMed ID: 11026093
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Pharmacological therapy of obesity].
    Pagotto U; Vanuzzo D; Vicennati V; Pasquali R
    G Ital Cardiol (Rome); 2008 Apr; 9(4 Suppl 1):83S-93S. PubMed ID: 18773755
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A randomised trial of a weight loss intervention for overweight and obese people diagnosed with coronary heart disease and/or type 2 diabetes.
    Gallagher R; Kirkness A; Zelestis E; Hollams D; Kneale C; Armari E; Bennett T; Daly J; Tofler G
    Ann Behav Med; 2012 Aug; 44(1):119-28. PubMed ID: 22552838
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A systematic review of commercial weight loss programmes' effect on glycemic outcomes among overweight and obese adults with and without type 2 diabetes mellitus.
    Chaudhry ZW; Doshi RS; Mehta AK; Jacobs DK; Vakil RM; Lee CJ; Bleich SN; Kalyani RR; Clark JM; Gudzune KA
    Obes Rev; 2016 Aug; 17(8):758-69. PubMed ID: 27230990
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Current and Emerging Pharmacotherapies for Weight Management in Prediabetes and Diabetes.
    Lau DC; Teoh H
    Can J Diabetes; 2015 Dec; 39 Suppl 5():S134-41. PubMed ID: 26654857
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Is there a role for surgery in the treatment of type 2 diabetes?].
    Benedix F; Meyer F; Klose S; Stroh C; Lippert H
    Dtsch Med Wochenschr; 2014 Jan; 139(5):207-12. PubMed ID: 24449355
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Behavioral Lifestyle Interventions for Weight Loss in Overweight or Obese Patients with Type 2 Diabetes: A Systematic Review of the Literature.
    Gostoli S; Raimondi G; Popa AP; Giovannini M; Benasi G; Rafanelli C
    Curr Obes Rep; 2024 Jun; 13(2):224-241. PubMed ID: 38436787
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Predictors of Diet-Induced Weight Loss in Overweight Adults with Type 2 Diabetes.
    Berk KA; Mulder MT; Verhoeven AJ; van Wietmarschen H; Boessen R; Pellis LP; van T Spijker A; Timman R; Ozcan B; Sijbrands EJ
    PLoS One; 2016; 11(8):e0160774. PubMed ID: 27494531
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Salba-chia (Salvia hispanica L.) in the treatment of overweight and obese patients with type 2 diabetes: A double-blind randomized controlled trial.
    Vuksan V; Jenkins AL; Brissette C; Choleva L; Jovanovski E; Gibbs AL; Bazinet RP; Au-Yeung F; Zurbau A; Ho HV; Duvnjak L; Sievenpiper JL; Josse RG; Hanna A
    Nutr Metab Cardiovasc Dis; 2017 Feb; 27(2):138-146. PubMed ID: 28089080
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Systematic review of long-term weight loss studies in obese adults: clinical significance and applicability to clinical practice.
    Douketis JD; Macie C; Thabane L; Williamson DF
    Int J Obes (Lond); 2005 Oct; 29(10):1153-67. PubMed ID: 15997250
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Lifestyle-recommendations on weight loss in type 2 diabetes--useful, or not?].
    Admiraal WM; Holleman F; Hoekstra JB
    Ned Tijdschr Geneeskd; 2013; 157(43):A6813. PubMed ID: 24152367
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy and safety of rimonabant for improvement of multiple cardiometabolic risk factors in overweight/obese patients: pooled 1-year data from the Rimonabant in Obesity (RIO) program.
    Van Gaal L; Pi-Sunyer X; Després JP; McCarthy C; Scheen A
    Diabetes Care; 2008 Feb; 31 Suppl 2():S229-40. PubMed ID: 18227491
    [TBL] [Abstract][Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 14.